Ctm PrP) is involved in the neurodegeneration process during inherited and infectious prion diseases but a causative relationship has never been established. We wanted to know if and how the proposed transmembrane domain of PrP could induce neuronal dysfunction. Thus, we investigated the neurotoxic properties of two peptides whose sequences are encompassed within this domain. We show that PrP peptides 118 -135 and 105-132 as well as an amidated more soluble peptide 105-132 induce the death of pure cortical neurons originating from normal and PrP knockout mice. This can be correlated with the high propensity of these peptides to insert stably into and to destabilize cell membranes. Through this study, we have identified a novel mechanism of neurotoxicity for PrP, which directly involves membrane perturbation; this mechanism is independent of fibril formation and probably corresponds to the effect of the transmembrane insertion of Ctm PrP.
INTRODUCTION
Transmissible subacute spongiform encephalopathies, also named prion diseases, constitute a heterogeneous group of infectious, sporadic, and inheritable conditions. The histopathological hallmarks of prion diseases encompass spongiosis with neuronal vacuolation, neuronal loss, astrocytosis, and usually the accumulation of a protein named PrPres (Beck et al., 1966; Lucassen et al., 1995) . This protein represents an abnormal isoform of a host 33-to 35-kDa sialoglycoprotein, the cellular prion protein or PrPc (Stahl et al., 1992) . Local accumulation of PrPres in certain areas of the brain precedes, in most cases, the onset of neuropathological hallmarks (DeArmond et al., 1989; Williams et al., 1997) but the correlation between PrPres accumulation and neurodegeneration is not always demonstrated (Hegde et al., 1998; Hsiao et al., 1994) . In vitro, a PrP-related peptide encompassing residues 106 to 126 has been shown to induce neuronal death (Forloni et al., 1993 (Forloni et al., , 1994 . Recent evidences suggest that this toxicity may be induced through the activation of glial cell and the concomittant production of cytokines and free radicals (Brown et al., 1996; Peyrin et al., 1999) rather than or in addition to acting directly on the neurons. Moreover, the requirement of PrP expression by neuronal cells is still unclear since it has been recently shown that PrP expressing astrocytes can mediate the toxicity on PrP nonexpressing neurons (Brown, 1999) .
PrPc is an extracellular protein attached to the plasma membrane by a glycosylphosphatidylinositol anchor (Stahl et al., 1992) . Hegde et al. have shown 
